key: cord-0722395-qf3md57d
authors: Ascani, Claudio; Passaretti, Daniele; Scacchi, Marco; Bullitta, Gianluca; De Cupis, Mauro; Pasqualetto, Monia; Ascani, Jacopo
title: Can Adhesive Capsulitis of the shoulder be a consequence of COVID-19? Case series of 12 patients.
date: 2021-05-05
journal: J Shoulder Elbow Surg
DOI: 10.1016/j.jse.2021.04.024
sha: e6970c2d4481a62477a9944a8fcf65b02a2d53a2
doc_id: 722395
cord_uid: qf3md57d

nan

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has spread explosively 3 throughout the world, resulting in a pandemic new respiratory disease identified as 4 coronavirus disease 2019 (COVID-19). Since March 2020, the viral infection has affected at 5 least 192 countries or regions, causing about 2.5 million deaths and infecting more than 112 6 million people 25 . 7

Patients with COVID-19 can be classified in 3 groups according to the severity of the viral 8 infection 13, 44 : i) Asymptomatic and Mild COVID-19 patients, who account for the majority of 9 cases, (approx. 80%), ii) Severely ill patients (14%) and iii) Critical patients (6%) 13, 44 . 10 COVID-19 symptoms differ in the three groups 44 . Patients with mild symptoms generally 11 suffer from nasal congestion, fever, anosmia and dysgeusia, a sore throat, cough, headache, 12 malaise and myalgia. Patients with a severe presentation frequently require hospitalization 13 owing to pneumonia and acute respiratory distress syndrome. The symptoms in critical 14 patients include respiratory failure, septic shock, multiorgan dysfunction syndrome and 15 disseminated intravascular coagulation 44 . 16 SARS-CoV-2 on infected target cells and of the indirect effects due to the host's 23 inflammatory response to the virus. In particular, the indirect effects are associated with a 24 cytokine storm and a systemic inflammation that involve any organ or system, including the 25 musculoskeletal system 4, 21 . 26

The main musculoskeletal manifestations that have to date been associated with COVID-19 27 are myalgias and generalized weakness, which are reported as early, transient features in 15 -28 45% of symptomatic patients and resolve on average within 10 -15 days 19,34,45 . Arthralgia is 29 another common symptom, that is often combined with myalgias 7 . Lastly, high blood 30 creatinine kinase levels are often present in severe and critical patients 7,21 . 31

Less is known about joint symptoms, with no studies having yet been published on 32 inflammation of the synovial tissue or joint fibrosis related to COVID-19. 33

Among the inflammatory diseases involving the shoulder and associated with an 34 overexpression of inflammatory cytokines is Adhesive Capsulitis (AC) 28 . Described for the 35 first time in 1872 by Duplay 9 and subsequently also defined as frozen shoulder by Codman 5 , 36 AC is characterized by shoulder pain and stiffness combined with reduced active and passive 37 range of motion and may severely impair a person's quality of life. 38

Several studies 16, 26, 28, 33, 36 show that the beginning of the pathological process in AC is 39 characterized by a gleno-humeral inflammation followed by synovial and periarticular 40 fibrosis 16,26,28,33,36 . Based on reports that the inflammatory reaction in AC 28,36 shows several 41 similarities to that in COVID-19, and that synovial cells may be targeted by the SARS-CoV-42 examination, was based on: a reduction in both active and passive range of motion (ROM) of 51 the shoulder, evaluated in the sitting and supine positions; no strength reduction in intra-52 extrarotation; exclusion of the postero-superior 18,24,27,29,35,42 and anterior 1,11,41 rotator cuff 53 tendon tears; an X-ray evaluation: true AP view (with the central ray tangential to the glenoid 54 surface) and a Velpeau Axillary view (with the patient's arm held in internal rotation, the ray 55 is superior to inferior and the patient leaning backward); a MRI of the involved shoulder. 56

All the patients were evaluated between 15th November 2020 and 15th January 2021 at the 57 shoulder surgery unit at our hospital, and all reported shoulder stiffness and pain arising after 58 COVID-19, with no apparent cause. 59

At the time of our examination, none of the patients enrolled referred the following: a recent 60 shoulder trauma; previous diagnosis of adhesive capsulitis in either shoulder; a previous 61 ROM limitation or a rotator cuff tear; severe gleno-humeral osteoarthritis; cervical spine 62 symptoms, rheumatologic and/or autoimmune pathologies. 63

The total number of patients and those with adhesive capsulitis evaluated during the study 64 period were noted. Clinical information on gender, age, affected side, time of AC onset after 65 COVID-19 diagnosis, severity of COVID-19, shoulder functional limitation and pain 66 intensity was recorded. All comorbidities, as possible risk factors for development of 67 adhesive capsulitis, were noted. 68

Passive shoulder ROM was evaluated in terms of forward elevation, abduction and external 69 rotation (with the arm at the side and elbow flexed at 90 degrees). The visual analogue scale 70 (VAS) was used to assess pain intensity 22 . 71

All the patients signed an informed consent form in accordance with the Declaration of 72

During the study period, a total of 1120 patients were evaluated at our shoulder surgery unit. 76

Of these, 146 had an adhesive capsulitis of the shoulder. The study sample was composed of 77 12 patients: 8 female and four male. The patients' mean age was 57 years (range: 42-73). All 78 the clinical data are presented in Table I . 79

The right shoulder was involved in 5 subjects, the left shoulder in 6 subjects while one patient 80 reported symptoms in both shoulders. Adhesive capsulitis arose 1.5-3 months after the 81 COVID-19 diagnosis (mean time to onset: 2 months). 82

According to severity, COVID-19 in seven of the patients was asymptomatic whereas in the 83 remaining five patients symptoms were mild. None of the patients were severely or critical ill. 84

About other comorbidities, two patients had well-compensated diabetes mellitus." 85

The decrease in range of motion was as follows: mean Forward Elevation of the affected side 86 was 116° (range: 70°-170°) with a mean reduction compared with the uninjured shoulder of 87 54° (range: 10°-110°); Mean Abduction was 89° (range: 40°-150°) and mean External 88

Rotation was 15° (range: 0°-35°), with a mean reduction compared with the contralateral side 89 of 81° (range: 25°-140°) and 30° (range: 10°-50°), respectively. Mean pain intensity was 5.6 90 (range: 3-8). 91 The initial pathological process in adhesive capsulitis is known to be a synovial inflammation 97 associated with a hypervascular hyperplasia. This is followed by fibroblast hyperactivity and subsequent fibrosis in the synovium and gleno-humeral capsular tissue 28,36 , located above all 99 in the coraco-humeral ligament and to the rotator interval area 2,15,16,17,26,33 . 100

Active and passive motion limitations are characteristic in patients with AC and occur with 101 varying degrees of severity 37 . Shoulder pain intensity appears to be higher in the first 3 102 months following symptoms onset, in patients with a more severe range of motion 103 impairment and in females 3 . Lastly, the pain in AC is most frequently reported in the anterior 104 surface of the shoulder with irradiation downwards, to the antero-lateral aspect of the arm as 105 far as its distal third (dermatomes C5-C6) 3 . 106

In our series, the asymptomatic patients displayed a greater ROM impairment and a greater 107 intensity of pain than mild-symptomatic patients, though a statistical evaluation is unreliable 108 owing to the limited size of the sample. 109

As regards the correlation between COVID-19 and the frozen shoulder, we hypothesize that 

Effectiveness of convalescent plasma 203 therapy in severe COVID-19 patients

De la peri-arthrite scapulo-humerale et des raideurs de l'epaule qui en 206 sont la consequence

Coronaviruses: an overview of their replication and pathogenesis

Isolated rupture of the subscapularis tendon

A SARS-CoV-212 2 protein interaction map reveals targets for drug repurposing

Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease

Master Regulator Analysis of the SARS-218

Long-term outcome of frozen shoulder

The pathology of frozen shoulder